Gene Query: TCN2

Dataset Description Geneva Score
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 54.08
Generation and functional characterization of MDSC-like cells 50.21
Effects of rFVIIIFc on human macrophages 45.15
Gene expression analysis of immortalized human liver progenitor-like cells in culture 45.06
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 43.75
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 43.75
Macrophage Ad5f35 M2 Challenge 36.63
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 33.43
Statins modulate endothelial transcriptional profile by inhibiting EZH2 31.73
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 30.01
RNA Seq of HMVEC under hypoxia 29.74
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 29.74
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 29.04
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 28.95
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 28.36
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 28.36
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 28.32
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 28.07
Role of CD133 molecule in WNT response and renal repair 27.96
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 25.55
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 25.44
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 22.59
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 21.97
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 21.42
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 21.25
Tumor exosome integrins determine organotropic metastasis 18.56
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 18.43
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 16.68
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 16.6
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 16.59
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 16.41
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 16.31
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 16.21
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 16.01
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 15.75
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 15.75
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 15.33
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 14.97
Region-specific Innate Antiviral Responses of the Human Epididymis 14.68
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 14.43
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 13.99
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 13.48
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 13.01
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 12.83
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 12.56
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 12.53
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 12.53
RNA-sequencing of human liver tissue 12.43
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 12.21
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 12.21
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 12.08
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 12.01
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 11.88
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 11.82
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 11.71
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 11.15
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 10.83
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 10.82
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 10.61
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 10.5
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 10.46
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 10.26
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 10.17
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 10.14
RNA splicing alteration on glioblastoma and normal neural stem cells 10.09
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 10.08
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 10.03
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 9.98
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 9.86
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 9.67
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 9.64
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 9.58
Mechanistic Model-Guided Study of Embryonic Morphogenesis 9.52
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 9.45
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 9.41
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 9.36
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 9.3
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 9.3
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 9.22
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 9.17
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 9.14
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 9.14
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 9.14
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 9.14
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 9.13
Generation of KRAS signatures using immortalized isogenic lung cells. 9.02
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 9.0
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 8.84
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 8.8
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 8.8
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 8.8
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 8.58
Gene expression profile of multiple myeloma cell lines treated with CB-5083 8.44
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 8.37
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 8.28
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 8.27
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 8.27
Macrophage Ad5f35 PhenoMap 8.26
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 8.15
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 8.15
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 8.12
Next Generation Sequencing of human SMA and healthy control Motor Neurons 8.08
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 8.01
Exploring the RNA landscape of endothelial exosomes 7.98
Genome-wide identification of cancer-specific alternative splicing in circRNA 7.93
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 7.82
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 7.81
The role of FAM46C in myeloma cells [sequencing] 7.8
The role of FAM46C in myeloma cells 7.8
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 7.71
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 7.67
RNA-seq of naive and primed ES cells (NHSM) 7.65
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 7.61
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 7.58
Transcriptome analysis of CNS leukemia 7.55
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 7.55
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 7.54
Transcriptional dependencies in diffuse intrinsic pontine glioma 7.49
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 7.44
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 7.44
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 7.37
High level DNA repair gene expression in human ES cells 7.34
Molecular Mechanisms of Endothelial Hyperpermeability 7.33
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 7.29
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 7.2
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 7.15
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 7.15
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 7.1
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 7.01
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 6.99
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 6.9
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 6.9
Transcriptome of U251 cells overexpression complement component 7 6.89
Comparing gene expression in iPSC derived RPE from control and AMD donors 6.89
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 6.79
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 6.76
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 6.74
The effect of insulin on mRNA transcription of human pluripotent stem cells 6.62
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 6.62
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 6.62
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 6.62
Dermal endothelial cells of type 2 diabetic patients 6.55
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 6.53
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 6.49
Efficient derivation of microglia-like cells from human pluripotent stem cells 6.47
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 6.44
Gene expression profile difference among renal location in a stone former 6.42
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 6.41
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 6.4
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 6.4
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 6.32
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 6.24
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 6.18
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 6.12
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 6.09
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 6.08
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 6.0
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 5.97
Ectoderm specification of H1 human embryonic stem cells 5.97
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 5.94
Universal alternative splicing of noncoding exons 5.93
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 5.9
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 5.9
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 5.86
Transcriptome analysis of BAP1 knockout and restoration 5.86
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 5.85
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 5.83
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 5.81
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 5.81
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 5.8
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 5.79
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 5.79
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 5.77
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 5.76
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 5.76
RNA-seq of stable and unstable section of human atherosclerotic plaques 5.74
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 5.68
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 5.68
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 5.61
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 5.59
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 5.57
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 5.49
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 5.46
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 5.46
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 5.45
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 5.45
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 5.31
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 5.29
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 5.29
HNF1 regulates critical functions of the human epididymis epithelium. 5.29
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 5.27
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 5.23
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 5.22
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 5.18
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 5.18
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 5.18
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 5.12
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 5.11
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 5.1
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 5.08
DIGIT regulates endoderm differentiation of human embryonic stem cells 5.05
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 4.99
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 4.96
Molecular analysis of renal cell carcinoma with unclassfied histology 4.86
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 4.86
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 4.82
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 4.82
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 4.81
RNA sequencing with KSHV infection and enrichment for circular RNAs 4.76
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 4.73
RNA-sequencing of formalin fixed human primary melanoma tissue 4.73
CircRNAome diversity in human mature B-cells, T-cells and monocytes 4.67
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 4.62
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 4.62
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 4.59
Endometrial transcriptome and PGR cistrome in cycling fertile women 4.59
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 4.52
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 4.51
RNA-seq analysis of uveal melanoma cells treated with FR900359 4.47
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 4.45
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 4.41
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 4.4
Non-coding regions are the main source of tumor-specific antigens 4.38
Non-coding regions are the main source of tumor-specific antigens [human] 4.38
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 4.38
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 4.38
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 4.33
Maturation of human iNSCs 4.3
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 4.25
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 4.24
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 4.24
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 4.24
Transcriptome Profiling of Human Primary Monocytes 4.23
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 4.18
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 4.18
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 4.18
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 4.14
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 4.13
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 4.12
TGF-β promotes genomic instability after loss of RUNX3 4.12
FOXD3 is a novel tumor suppressor in lung cancer 4.09
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 4.04
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 4.03
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 4.0
Nonpregnant and term pregnant human myometrial tissues 4.0
Neonatal and adult human testis defined at the single-cell level 3.98
Engineering Patient-Specific Tissue Implants 3.94
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 3.9
Total RNA sequencing of APC mutant and wt colonic organoids 3.85
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 3.74
High-efficiency RNA-based reprogramming of human primary fibroblasts 3.69
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 3.68
ML29755 RNA-seq data 3.68
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 3.67
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 3.64
An acquired vulnerability of drug resistant melanoma with therapeutic potential 3.61
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 3.61
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 3.6
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 3.59
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 3.58
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 3.57
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 3.57
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 3.55
BI Human Reference Epigenome Mapping Project 3.53
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 3.51
Human embryonic stem cells in E8 and AKIT culture medium 3.51
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 3.48
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 3.48
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 3.46
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 3.43
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 3.43
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 3.42
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 3.42
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 3.4
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 3.4
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 3.4
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 3.4
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 3.4
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 3.36
Leucegene: AML sequencing (part 6) 3.31
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 3.3
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 3.28
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 3.21
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 3.14
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 3.1
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 3.09
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 3.09
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 3.02
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 2.99
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 2.99
Epigenome regulation during epidermal lineage commitment 2.98
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 2.94
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 2.9
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 2.9
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 2.9
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 2.9
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 2.86
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 2.8
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 2.78
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 2.76
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 2.74
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 2.72
Morphological and molecular characterization of human dermal lymphatic collectors 2.69
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 2.68
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 2.68
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 2.68
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 2.68
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 2.68
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 2.64
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 2.64
Expression profiling of converted and control dermal BJ fibroblasts 2.59
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 2.59
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 2.5
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 2.5
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 2.5
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 2.5
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.5
FGF2 regulation of gene expression in stable inducible Neurons 2.48
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 2.48
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 2.48
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 2.44
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 2.44
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 2.42
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 2.36
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 2.36
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 2.36
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 2.34
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 2.29
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 2.28
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 2.25
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 2.23
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 2.22
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 2.22
Transcriptome of Stabilin-1 siRNA transfected human monocytes 2.2
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 2.16
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 2.16
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 2.14
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 2.11
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 2.1
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 2.09
Transcriptome wide analysis of classically and alternatively activated macrophages 2.08
CD86 regulates a pro-survival signal in myeloma cells 2.07
Transcriptomic analysis of human macrophages in 3D 2.06
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 2.05
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 2.05
Finding missing proteins from epigenetically manipulated human cells 2.0
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 1.98
Transcriptome of human white and brown adipose tissue biopsies 1.97
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 1.97
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 1.95
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 1.95
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 1.92
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 1.91
Disruption of GRIN2B impairs differentiation in human neurons 1.91
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 1.89
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 1.88
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 1.77
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 1.77
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 1.76
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 1.74
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 1.73
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 1.73
Gene expression of collecting duct carcinoma of the kidney 1.64
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 1.61
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 1.59
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 1.57
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 1.56
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 1.55
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 1.55
Molecular Criteria for Defining the Naive Human Pluripotent State 1.52
The expression profiles of GBC liver metastasis 1.52
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 1.5
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 1.5
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 1.5
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 1.5
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 1.49
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 1.49
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 1.48
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 1.45
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 1.45
The DNA methylation landscape of human melanoma 1.44
The DNA methylation landscape of human melanoma [RNA-Seq] 1.44
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 1.43
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 1.43
Trascriptome of thyroid cancer-induced macrophages 1.41
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 1.37
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 1.35
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 1.32
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 1.32
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 1.32
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 1.3
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 1.3
An optimization system for isolating and sequencing of single human colon cancer cells 1.29
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 1.29
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 1.29
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 1.28
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 1.27
Endothelial gene expression analysis 1.27
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 1.25
Gene expression analysis of human adenomas. 1.25
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 1.2
JAK dependent survival of ALK- ALCL 1.19
RNA sequencing of human pancreatic cancer cell lines 1.19
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.18
MARS Seq data from human cortical organoids 1.13
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 1.13
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 1.11
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 1.11
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 1.11
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 1.1
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 1.06
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 1.06
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 1.06
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 1.05
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 1.05
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 1.05
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 1.04
Single-cell analysis of adult human ovary using 10X genomics 1.03
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 1.03
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 1.02
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 1.02
Hepatosplenic T cell lymphoma 0.99
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 0.99
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 0.99
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 0.99
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 0.97
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.93
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.92
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 0.89
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 0.89
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.89
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 0.86
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.83
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.83
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 0.79
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 0.78
Derivation and differentiation of haploid human embryonic stem cells 0.78
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 0.76
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 0.76
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.74
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 0.71
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.68
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.68
Gene expression profile of CRC-derived HILEC 0.66
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.61
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.61
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.6
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 0.58
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.57
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 0.56
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.56
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.55
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 0.55
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 0.54
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.53
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 0.51
Gene expression of thyroid cancer cell lines 0.51
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 0.48
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 0.47
quanTIseq: quantifying immune contexture of human tumors 0.43
Specific molecular signatures underlie response to decitabine in CMML 0.4
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.4
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.39
The Genetic Landscape of Diamond-Blackfan Anemia 0.38
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 0.38
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.36
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.36
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 0.36
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 0.36
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 0.36
Functional Haploid Human Oocytes Generated from Polar Body Genomes 0.36
SF3B1 Degron knockdown RNA-seq 0.35
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 0.34
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 0.33
hNSCs siRNA NOVA2 0.3
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 0.28
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 0.21
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.21
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 0.2
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 0.16
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.14
Expression patterns in chronic thromboembolic pulmonary hypertension 0.13
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 0.13
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.12
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.11
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.11
Epigenomic conservation of transposable element silencing 0.11
Epigenomic conservation of transposable element silencing [RNA-seq] 0.11
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 0.11
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 0.09
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.08
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.07
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.05
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 0.05
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 0.05
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 0.05
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 0.03
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 0.03
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.03
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation